This is an article about portfolio company, Levitas Bio.
NEW YORK – Levitas Bio, a Stanford University spinout, is preparing the launch of a technology that sounds nearly imaginary: magnetic levitation-based cell separation.
"Unlike anything else out there, when it comes to separating particles, we don't attach or bind anything to the cells," said CEO Martin Pieprzyk. "No dyes, no antibodies. It's touch free." The workflow requires only three steps and can be done in 20 minutes, he added.
View source version on genomeweb.com: https://www.genomeweb.com/sample-prep/stanford-spinout-levitas-bio-launch-magnetic-levitation-cell-separation-platform